We are live on ! Find out more
SGNT

SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT

Delisted

SGNT was delisted on the 29th of August, 2016.

Back to rankings

128 hedge funds and large institutions have $486M invested in SAGENT PHARMACEUTICALS INC COM STK (DE) in 2016 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 52 increasing their positions, 39 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

10,380% more call options, than puts

Call options by funds: $524K | Put options by funds: $5K

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

33% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 39

23% more capital invested

Capital invested by funds: $395M → $486M (+$90.3M)

6% less funds holding

Funds holding: 136 → 128 (-8)

33% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 21

Holders
128
Holders Change
-8
Holders Change %
-5.88%
% of All Funds
3.42%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.08%
New
14
Increased
52
Reduced
39
Closed
21
Calls
$524K
Puts
$5K
Net Calls
+$519K
Net Calls Change
+$93K

Top Buyers

Rank Fund Capital Flow
1
NIMC
NWQ Investment Management Company
California
+$16M
2
Ameriprise
Ameriprise
Minnesota
+$4.12M
3
TA
Tamarack Advisers
California
+$3.33M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$2.93M
5
BIT
BlackRock Institutional Trust
California
+$2.88M

Top Sellers

Rank Fund Capital Flow
1
EAM
EverPoint Asset Management
Connecticut
-$11M
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$8.33M
3
SAM
Sectoral Asset Management
Quebec, Canada
-$6.33M
4
Millennium Management
Millennium Management
New York
-$3.98M
5
Franklin Resources
Franklin Resources
California
-$1.69M
Name Holding Trade Value Shares
Change 		Change in
Stake
New York State Common Retirement Fund
26
New York State Common Retirement Fund
New York
$4.13M – – –
TA
27
Tamarack Advisers
California
$3.88M +$3.33M +259,336 New
Prudential Financial
28
Prudential Financial
New Jersey
$3.6M -$320K -24,940 -9%
FHAM
29
Folger Hill Asset Management
New York
$3.39M – – –
Deutsche Bank
30
Deutsche Bank
Germany
$3.31M -$132K -10,298 -4%
KA
31
Kerrisdale Advisers
Florida
$2.85M -$177K -13,754 -7%
RJA
32
Raymond James & Associates
Florida
$2.77M +$474K +36,872 +25%
Geode Capital Management
33
Geode Capital Management
Massachusetts
$2.62M -$34.6K -2,694 -2%
Principal Financial Group
34
Principal Financial Group
Iowa
$2.53M +$58K +4,518 +3%
RHJA
35
Rice Hall James & Associates
California
$2.42M +$742K +57,790 +56%
OAM
36
Oxford Asset Management
United Kingdom
$2.29M +$1.57M +121,945 +395%
CCMH
37
Cornerstone Capital Management Holdings
New York
$2.08M +$1.78M +138,700 New
Goldman Sachs
38
Goldman Sachs
New York
$1.98M -$462K -35,994 -21%
BA
39
BlackRock Advisors
Delaware
$1.88M +$1.15M +89,307 +245%
BIM
40
BlackRock Investment Management
Delaware
$1.8M +$440K +34,214 +40%
Bank of America
41
Bank of America
North Carolina
$1.79M +$1.29M +100,123 +520%
Mackenzie Financial
42
Mackenzie Financial
Ontario, Canada
$1.64M +$380K +29,600 +37%
TCIM
43
TIAA CREF Investment Management
New York
$1.63M +$64.3K +5,009 +5%
Invesco
44
Invesco
Georgia
$1.62M +$5.83K +454 +0.4%
JAM
45
JW Asset Management
Florida
$1.52M – – –
Ohio Public Employees Retirement System (OPERS)
46
Ohio Public Employees Retirement System (OPERS)
Ohio
$1.49M – – –
PAMU
47
Pictet Asset Management (UK)
United Kingdom
$1.45M – – –
ACM
48
Argent Capital Management
Missouri
$1.4M +$228K +17,775 +24%
TC
49
TFS Capital
Pennsylvania
$1.39M -$1.08M -84,282 -48%
MC
50
Menta Capital
California
$1.23M +$263K +20,510 +33%
1
2
3 4 5

SGNT Hedge Fund Activity: Q2 2016 in Review

128 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) for Q2 2016, worth a combined $486M — up 23% from $395M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of SGNT and 14 opened new positions — a net loss of 7 holders — while 39 trimmed existing stakes and 52 added.

The largest buyer was NWQ Investment Management Company, opening a new position worth an estimated $16M. The largest seller was EverPoint Asset Management, exiting entirely with an estimated $11M sold.

  • 128 institutional investors held SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) as of Q2 2016, down from 136 in Q1 2016.
  • Funds reported $486M of SAGENT PHARMACEUTICALS INC COM STK (DE) stock for Q2 2016, up 23% quarter-over-quarter.
  • 14 funds opened new SAGENT PHARMACEUTICALS INC COM STK (DE) positions in Q2 2016 and 21 closed out, a net change of -7 holders.
  • The largest SAGENT PHARMACEUTICALS INC COM STK (DE) buyer in Q2 2016 was NWQ Investment Management Company, an estimated $16M added.
  • The largest SAGENT PHARMACEUTICALS INC COM STK (DE) seller in Q2 2016 was EverPoint Asset Management, an estimated $11M sold.

Based on aggregated 13F filings for Q2 2016.